Use of transgenic animals in toxicology

Pharmaceutical Science and Technology Today

Volumn 1, Issue 2, 1998, Pages 62-68

  Kirkland, David J ^a  

^a UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; DRUG CARCINOGENICITY; DRUG INDUSTRY; DRUG RESEARCH; GENETIC ENGINEERING; GENOTOXICITY; NONHUMAN; REVIEW; RISK ASSESSMENT; TOXICITY TESTING; TOXICOLOGY; TRANSGENIC ANIMAL;

EID: 0032077056     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(98)00016-9     Document Type: Review

References (50)

1. 1 Amundadottir, L.T., Merlino, G. and Dickson, R.D. (1996) Br. Cancer Res. Treat. 39, 119-135
2. 2 Hall, P.A. and Lemoine, N.R. (1993) Cancer Surv. 16, 135-155
3. 3 Thompson, T.C. et al. (1993) Cancer 71 (Suppl. 3), 1165-1171
4. 4 Mazarakis, N.D. et al. (1996) Genes Cells 1, 125-137
5. 5 Naash, M.I. et al. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 5499-5503
6. 6 Bruijn, L.I. and Cleveland, D.W. (1996) Neuropathol. Appl. Neurobiol. 22, 373-387
7. 7 Moreau-Gachelin, F. et al. (1996) Mol. Cell. Biol. 16, 2453-2463
8. 8 McCune, S.L. et al. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 9852-9856
9. 9 Prusiner, S.B. (1991) Crit. Rev. Biochem. Mol. Biol. 26, 397-438
10. 10 French, M.B. et al. (1997) Diabetes 46, 34-39
11. 11 Aguzzi, A. et al. (1994) Brain Pathol. 4, 3-20
12. 12 Frautschy, S.A. et al. (1996) Neurobiol. Aging 17, 311-321
13. 13 Nomura, T. (1997) Lab. Anim. Sci. 47, 113-117
14. 14 Koike, S.C. et al. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 951-955
15. 15 ICH (1997) Topic S6: Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Step 4 document, ICH4 meeting, Brussels
16. 16 Andre, C. et al. (1996) Eur. J. Biochem. 241, 417-424
17. 17 Udagawa, N. et al. (1995) J. Exp. Med. 182, 1461-1468
18. 18 Dombrowicz, D. et al. (1996) J. Immunol. 157, 1645-1651
19. 19 Yeung, R.S. et al. (1996) Eur. J. Immunol. 26, 1074-1082
20. 20 Altmann, D.M. et al. (1995) J. Exp. Med. 181, 867-875
21. 21 Tice, R.R., Andrews, P.W. and Singh, N.P. (1990) DNA Damage and Repair in Human Tissues (Sutherland, B.M. and Woodhead, A.D., eds), pp. 291-301, Plenum Press
22. 22 Randerath, K., Reddy, M.V and Gupta, R.C. (1981) Proc. Natl. Acad. Sci. U.S.A. 78, 6126-6129
23. 23 ICH (1997) Topic S2B: Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Step 4 document, ICH4 meeting, Brussels
24. 24 Gossen, J.A. et al. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 7971-7975
25. 25 Kohler, S.W. et al. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 7958-7962
26. 26 Kohler, S.W. et al. (1991) Environ. Mol. Mutagen. 18, 316-321
27. 27 Swiger, R.R., Myhr, B. and Tucker, J.D. (1994) Mutat. Res. 325, 145-148
28. 28 Gossen, J.A. et al. (1992) Nucleic Acids Res. 20, 3254
29. 29 Dean, S.W. and Myhr, B. (1994) Mutagenesis 9, 183-185
30. 30 Brooks, T.M. et al. (1995) Mutagenesis 10, 149-150
31. 31 Jakubczak, J.L. et al. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 9073-9078
32. 32 Brault, D. et al. (1996) Mutat. Res. 360, 83-87
33. 33 Ashby, J. and Mirkova, E. (1987) Mutagenesis 2, 199-204
34. 34 Brooks, T.M. and Dean, S.W. (1996) Mutagenesis 11, 529-532
35. 35 Myhr, B.C. (1991) Environ. Mol. Mutagen. 18, 308-315
36. 36 Coates, A. and Dean, S.W. Mutagenesis (in press)
37. 37 Shephard, S.E., Gunz, D. and Schlatter, C. (1995) Food Chem. Toxicol. 33, 257-264
38. 38 Morrison, V. and Ashby, J. (1994) Mutagenesis 9, 367-375
39. 39 Heddle, J.A. et al. (1995) Mutagenesis 10, 467-470
40. 40 ICH (1997) Topic S1B: Carcinogenicity: Testing for Carcinogenicity of Pharmaceuticals. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Step 4 document, ICH4 meeting, Brussels
41. 41 Hasegawa, R. and Ito, N. (1992) Food Chem. Toxicol. 30, 979-992
42. 42 Hasegawa, R. et al. (1994) Carcinogenesis 15, 2567-2573
43. 43 Fujii, K. (1991) Carcinogenesis 12, 1409-1415
44. 44 Tennant, R.W., French, J.E. and Spalding, J. (1995) Environ. Health Perspect. 103, 942-950
45. 45 Tennant, R.W., Spalding, J. and French, J.E. (1996) Mutat. Res. 365, 119-127
46. 46 Yamamoto, S. et al. (1996) Carcinogenesis 17, 2455-2461
47. 47 Yamamoto, S. et al. (1997) Lab. Anim. Sci. 47, 121-126
48. 48 De Vries, A. and Van Steeg, H. (1996) Semin. Cancer Biol. 7, 229-240
49. 49 Berg, R. W.J. et al. (1997) Cancer Res. 57, 581-584
50. 50 De Vries, A. et al. (1997) Carcinogenesis 18, 2327-2332